In the CRS protocol, mice receiving Treg cells showed a decrease in the frequency of effector CD4+ CD44hi T cells and a recovery of TGF-β expression in the spleen, which could be interpreted as anti-inflammatory response (Pure and Cuff, 2001). Here, TGFB1 is linked to congenital rubella syndrome.